In order to prevent and control infection in operating rooms for patients with suspected or confirmed coronavirus disease 2019(COVID-19), according to treatment plan and technical guidelines for COVID-19 issued by National Health Commission of the People's Republic of China, as well as relevant laws and regulations of national infection prevention and control, referring to the existing experience of nursing management in operating rooms across the country, combining with the management suggestions of infection control experts in China, Expert consensus on infection prevention and control for COVID-19 suspected or confirmed patients in operating rooms in China is established. This consensus is based on the characteristics of infection prevention and control in COVID-19 patients undergoing surgery, and is elaborated from aspects of preparation before surgery, prevention and control during surgery, prevention and control after surgery, as well as other attentions, which has certain scientific and practical significance, and can provide clinical guidance for infection prevention and control of COVID-19 patients in operating rooms.

In order to better prevent novel coronavirus (2019-nCoV) healthcare-associated infection, ensure the safety of health care workers(HCWs) and other staff in medical institutions, and rationally use personal protective equipment(PPE), Healthcare-associated Infection Control Branch of Chinese Preventive Medicine Association, Healthcare-associated Infection Management Committee of Chinese Hospital Association, and Chinese Journal of Infection Control jointly organize domestic experts (including some experts on the frontline of anti-epidemic in Wuhan) to jointly formulate this consensus. This consensus is mainly applicable for medical institutions which receive and cure both patients with coronavirus disease 2019 (COVID-19) and common patients; guide frontline HCWs, non-frontline HCWs, and other staff in medical institutions to rationally and effectively use protective equipment. This consensus determines personal protection standards of staff at different locations and with different working posts through assessment on risk of exposure to COVID-19 among staff in medical institutions. The main contents of this consensus also include introduction and application scope of PPE, putting on and taking off process of three level protection, prevention and emergency treatment of abnormal PPE, treatment process of occupational exposure to COVID-19. At the same time, this consensus particularly emphasizes the rational division of medical institutions during COVID-19 epidemic period, arrange experienced clinicians of departments of infectious or respiratory diseases participate in triage at key triage location, which are the prerequisite requirements of risk assessment; for the selection of PPE, we should not only prevent inadequate protection, but also avoid abuse and overuse, so as to prevent HAI on the premise of ensuring the safety of staff.

近一个世纪以来，抗菌药物在人类战胜各种感染性疾病的过程中发挥了关键作用，但日益突出的多重耐药菌问题已给临床抗感染治疗带来了严峻挑战。如何有效减缓多重耐药菌的产生，阻断多重耐药菌传播，已引起医学界、政府与社会的广泛关注。为加强多重耐药菌的医院感染管理，有效预防和控制多重耐药菌在医院内的产生和传播，保障患者的安全，由中国感染控制杂志组织，58位国内知名专家共同发起,邀请全国165位专家参与,历时10个月,召开了9场专题讨论会,在充分收集意见和讨论的基础上,最终形成了《多重耐药菌医院感染预防与控制中国专家共识》。共识荟萃了国内外多重耐药菌医院感染防控的最新进展,总结了我国大多数权威专家防控方面的宝贵经验,旨在规范和指导我国多重耐药菌医院感染的防控，提高我国多重耐药菌感染防控水平。